Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients

NCT05944458 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Linezolid
Antioxidant
Thrombocytopenia
Critical Illness
ICU

Interventions

DRUG: N acetyl cysteine
DRUG: Placebo

Sponsor

Helwan University